Please provide your email address to receive an email when new articles are posted on . Ninety-five percent of patients achieved treatment success at 8 weeks after administration of Rebyota via ...

SAN DIEGO -- Administering fecal microbiota via colonoscopy instead of rectally prevented recurrence of Clostridium difficile (C. diff) for up to 2 months with no major safety signals, according to a ...

Canadian researchers conducted a clinical trial at three academic centers in Alberta, Canada. The trial included 116 adult patients with recurrent C. diff, enrolled between October 2014 and September ...

When comparing four treatments for recurrent Clostridium difficile, researchers found fecal microbiota transplant colonoscopies may be the most cost effective, according to a study in Clinical ...

The digestive disorder known as Clostridium difficile, or C. diff, is a potentially life-threatening intestinal infection, but there is an option out there that's fast and has about a 90-percent ...

Human waste has long been thought of as just that: everything the body doesn’t want or need. But new research is showing that feces may contain valuable organisms that can actually treat disease. In a ...

C. difficile bacterium Oral capsule FMT and colonoscopy delivery showed similar patient outcomes, low rate differences, and high success rates. Oral capsule fecal microbiota transplantation (FMT) was ...

C. diff, which is short for Clostridioides difficile, is a type of bacteria that may cause serious problems in the digestive system. It is one of the most common causes of diarrhea linked to ...